Despite the looming uncertainty of President-elect Donald Trump's trade and tax policies, Wall Street is largely aligning ...
Traws Pharma says tivoxavir marboxi showed safety and tolerability in Phase I trial. Traws Pharma stock has quadrupled from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback